scholarly journals The Notch Signaling Pathway Is Related to Neurovascular Progression of Pancreatic Cancer

2005 ◽  
Vol 242 (6) ◽  
pp. 791-801 ◽  
Author(s):  
Peter B??chler ◽  
Amiq Gazdhar ◽  
Mario Schubert ◽  
Nathalia Giese ◽  
Howard A. Reber ◽  
...  
Oncotarget ◽  
2015 ◽  
Vol 7 (3) ◽  
pp. 3217-3232 ◽  
Author(s):  
Sivapriya Ponnurangam ◽  
Prasad R. Dandawate ◽  
Animesh Dhar ◽  
Ossama W. Tawfik ◽  
Rajashri R. Parab ◽  
...  

2012 ◽  
Author(s):  
Shinichi Yabuuchi ◽  
Roeland F. de Wilde ◽  
Nathaniel Campbell ◽  
Elizabeth De Oliveira ◽  
Zeshaan Rasheed ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Yanli Xu ◽  
Shan Xu ◽  
Yueqin Cai ◽  
Luming Liu

The dire prognosis of pancreatic cancer has not markedly improved during past decades. The present study was carried out to explore the effect of Qingyihuaji formula (QYHJ) on inhibiting pancreatic cancer and prolonging survival in related Notch signaling pathway. Proliferation of pancreatic cancer cells (SW1990 and PANC-1) was detected by MTT assay at 24, 48, and 72 h with exposure to various concentrations (0.08–50 mg/mL) of QYHJ water extract. Pancreatic tumor models of nude mice were divided into three groups randomly (control, QYHJ, and gemcitabine). mRNA and protein expression of Notch target genes (Hes-1, Hey-1, Hey-2, and Hey-L) in dissected tumor tissue were detected. Results showed that proliferation of SW1990 cells and PANC-1 cells was inhibited by QYHJ water extract in a dose-dependent and time-dependent manner. QYHJ effectively inhibited tumor growth and prolonged survival time in nude mice. Expression of both Hes-1 and Hey-1 was decreased significantly in QYHJ group, suggesting that Hes-1 and Hey-1 in Notch signaling pathway might be potential targets for QYHJ treatment. This research could help explain the clinical effectiveness of QYHJ and may provide advanced pancreatic cancer patients with a new therapeutic option.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jin Xu ◽  
Weixue Xu ◽  
Xuan Yang ◽  
Zhen Liu ◽  
Yiya Zhao ◽  
...  

Abstract Background Pancreatic cancer (PCa) is a fatal malignancy with poor prognosis, high recurrence and mortality. Substantial reports have suggested long non-coding RNAs (lncRNAs) are implicated in development of numerous malignant tumors, and PCa is included. However, the correlation between novel lncRNA mir-99a-let-7c cluster host gene (MIR99AHG) and PCa remains elusive and needs to be deeply investigated. Methods In this study, we firstly used RT-qPCR to examine MIR99AHG expression. Functional assays were implemented for determination of the role of MIR99AHG in PCa cells. Mechanism experiments were designed and carried out for exploring the regulatory mechanism involving MIR99AHG. Results MIR99AHG was distinctly overexpressed in PCa cell lines. MIR99AHG deficiency abrogated PCa cell proliferation, migration and invasion. Moreover, MIR99AHG up-regulation was induced by transcription factor forkhead box A1 (FOXA1). Furthermore, MIR99AHG modulated notch receptor 2 (NOTCH2) expression and stimulated Notch signaling pathway through sequestering microRNA-3129-5p (miR-3129-5p) and recruiting ELAV like RNA binding protein 1 (ELAVL1). Conclusions Altogether, the exploration of FOXA1/MIR99AHG/miR-3129-5p/ELAVL1/NOTCH2 axis in the progression of PCa might provide a meaningful revelation for PCa diagnosis and treatment.


Sign in / Sign up

Export Citation Format

Share Document